Literature DB >> 18541996

The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update.

Valeriya Lyssenko1.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to provide a comprehensive evaluation of the most important type 2 diabetes gene to date, transcription factor 7 like-2. RECENT
FINDINGS: An important step to find genetic causes of type 2 diabetes in 2006 was the identification of the fact that variants in the gene encoding transcription factor 7 like-2 reproducibly increase susceptibility to type 2 diabetes in almost all populations studied. This gene has since then emerged as the most important type 2 diabetes gene. Genetic variants in transcription factor 7 like-2 confer a strong risk of type 2 diabetes possibly mediated by altering expression of transcription factor 7 like-2 in pancreatic islets. Risk variants in the transcription factor 7 like-2 influence insulin secretions both in vitro and in vivo. The risk T allele of this single nucleotide polymorphism also seems to have effects on the enteroinsular axis and the relationship between the incretin hormone glucose-dependent insulinotropic peptide and its target hormones, glucagon and insulin. Given transcription factor 7 like-2s' central role in the Wnt signaling pathway, it would be important to define whether the variant is associated with increased or decreased Wnt signaling.
SUMMARY: The fact that transcription factor 7 like-2 is by far the strongest type 2 diabetes susceptibility gene to date emphasizes the importance of exploring the potential of manipulating this pathway in future treatment of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541996     DOI: 10.1097/MCO.0b013e328304d970

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  12 in total

1.  Alterations in TCF7L2 expression define its role as a key regulator of glucose metabolism.

Authors:  Daniel Savic; Honggang Ye; Ivy Aneas; Soo-Young Park; Graeme I Bell; Marcelo A Nobrega
Journal:  Genome Res       Date:  2011-06-14       Impact factor: 9.043

2.  Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis.

Authors:  Pedro Cisternas; Paulina Salazar; Carmen Silva-Álvarez; L Felipe Barros; Nibaldo C Inestrosa
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

3.  Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

Authors:  K Faerch; K Borch-Johnsen; J J Holst; A Vaag
Journal:  Diabetologia       Date:  2009-07-10       Impact factor: 10.122

4.  Unique Interactome Network Signatures for Peroxisome Proliferator-activated Receptor Gamma (PPARγ) Modulation by Functional Selective Ligands.

Authors:  Vinh Q Lam; Jie Zheng; Patrick R Griffin
Journal:  Mol Cell Proteomics       Date:  2017-09-29       Impact factor: 5.911

5.  Transcriptional enhancers in development and disease.

Authors:  Noboru Jo Sakabe; Daniel Savic; Marcelo A Nobrega
Journal:  Genome Biol       Date:  2012-01-23       Impact factor: 13.583

6.  Modulation ofTcf7l2 expression alters behavior in mice.

Authors:  Daniel Savic; Margaret G Distler; Greta Sokoloff; Nancy A Shanahan; Stephanie C Dulawa; Abraham A Palmer; Marcelo A Nobrega
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

7.  An in vivo cis-regulatory screen at the type 2 diabetes associated TCF7L2 locus identifies multiple tissue-specific enhancers.

Authors:  Daniel Savic; Graeme I Bell; Marcelo A Nobrega
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

8.  The double trouble of metabolic diseases: the diabetes-cancer link.

Authors:  Slavica Tudzarova; Mahasin A Osman
Journal:  Mol Biol Cell       Date:  2015-09-15       Impact factor: 4.138

9.  Association between the rs7903146 Polymorphism in the TCF7L2 Gene and Parameters Derived with Continuous Glucose Monitoring in Individuals without Diabetes.

Authors:  Sabrina van der Kroef; Raymond Noordam; Joris Deelen; Abimbola A Akintola; Steffy W M Jansen; Iris Postmus; Carolien A Wijsman; Marian Beekman; Simon P Mooijaart; P Eline Slagboom; Diana van Heemst
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

Review 10.  Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer.

Authors:  Yves Lecarpentier; Victor Claes; Alexandre Vallée; Jean-Louis Hébert
Journal:  PPAR Res       Date:  2017-02-19       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.